108 related articles for article (PubMed ID: 10619792)
41. High-dose chemotherapy (HDC) with autologous bone marrow transplantation (ABMT) for the treatment of breast cancer: the jury is still out.
Smith GA; Henderson IC
Important Adv Oncol; 1995; ():201-14. PubMed ID: 7672807
[No Abstract] [Full Text] [Related]
42. Pulmonary toxicity of high-dose chemotherapy for breast cancer: a non-invasive approach to diagnosis and treatment.
Chap L; Shpiner R; Levine M; Norton L; Lill M; Glaspy J
Bone Marrow Transplant; 1997 Dec; 20(12):1063-7. PubMed ID: 9466279
[TBL] [Abstract][Full Text] [Related]
43. Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support.
Gilbert C; Meisenberg B; Vredenburgh J; Ross M; Hussein A; Perfect J; Peters WP
J Clin Oncol; 1994 May; 12(5):1005-11. PubMed ID: 8164024
[TBL] [Abstract][Full Text] [Related]
44. Pulmonary function and complications following chemotherapy and stem cell support in breast cancer.
Fanfulla F; Pedrazzoli P; Da Prada GA; Bruschi C; Dacosto E; Zambelli A; della Cuna GR; Rampulla C
Eur Respir J; 2000 Jan; 15(1):56-61. PubMed ID: 10678621
[TBL] [Abstract][Full Text] [Related]
45. Fatal re-expansion pulmonary edema associated with increased lung IL-8 levels following high-dose chemotherapy and autologous stem cell transplant.
Garantziotis S; Bhalla KS; Long GD; Vredenburgh JJ; Folz RJ
Respiration; 2002; 69(4):351-4. PubMed ID: 12169751
[TBL] [Abstract][Full Text] [Related]
46. High-dose chemotherapy with autologous bone marrow transplantation for the treatment of metastatic breast cancer.
Eddy DM
J Clin Oncol; 1992 Apr; 10(4):657-70. PubMed ID: 1285731
[TBL] [Abstract][Full Text] [Related]
47. High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry.
Berry DA; Broadwater G; Klein JP; Antman K; Aisner J; Bitran J; Costanza M; Freytes CO; Stadtmauer E; Gale RP; Henderson IC; Lazarus HM; McCarthy PL; Norton L; Parnes H; Pecora A; Perry MC; Rowlings P; Spitzer G; Horowitz MM
J Clin Oncol; 2002 Feb; 20(3):743-50. PubMed ID: 11821456
[TBL] [Abstract][Full Text] [Related]
48. High-dose chemotherapy and peripheral blood progenitor cell transplantation in the treatment of breast cancer.
Peters WP; Dansey RD; Klein JL; Baynes RD
Oncologist; 2000; 5(1):1-13. PubMed ID: 10706643
[TBL] [Abstract][Full Text] [Related]
49. Pulmonary drug toxicity following high-dose chemotherapy with autologous bone marrow transplantation: CT findings in 20 cases.
Patz EF; Peters WP; Goodman PC
J Thorac Imaging; 1994; 9(2):129-34. PubMed ID: 8207780
[TBL] [Abstract][Full Text] [Related]
50. Effect of radiotherapy and chemotherapy on pulmonary function after treatment for breast cancer and lymphoma: A follow-up study.
Theuws JC; Muller SH; Seppenwoolde Y; Kwa SL; Boersma LJ; Hart GA; Baas P; Lebesque JV
J Clin Oncol; 1999 Oct; 17(10):3091-100. PubMed ID: 10506604
[TBL] [Abstract][Full Text] [Related]
51. High-dose chemotherapy with stem-cell rescue for the treatment of breast cancer.
McCauley DL
Am J Health Syst Pharm; 1996 Mar; 53(5):521-34; quiz 561-2. PubMed ID: 8697012
[TBL] [Abstract][Full Text] [Related]
52. Empiric prednisone therapy for pulmonary toxic reaction after high-dose chemotherapy containing carmustine (BCNU).
Kalaycioglu M; Kavuru M; Tuason L; Bolwell B
Chest; 1995 Feb; 107(2):482-7. PubMed ID: 7842781
[TBL] [Abstract][Full Text] [Related]
53. Airway inflammation predicts diffuse alveolar hemorrhage during bone marrow transplantation in patients with Hodgkin disease.
Sisson JH; Thompson AB; Anderson JR; Robbins RA; Spurzem JR; Spence PR; Reed EC; Armitage JO; Vose JM; Arneson MA
Am Rev Respir Dis; 1992 Aug; 146(2):439-43. PubMed ID: 1489136
[TBL] [Abstract][Full Text] [Related]
54. Acute systolic dysfunction within two weeks of high-dose chemotherapy conditioning before autologous bone marrow transplant: a case report.
Gupta R; Murray C; Lazzara R; Sivaram CA
Echocardiography; 2008 Aug; 25(7):764-7. PubMed ID: 18462404
[TBL] [Abstract][Full Text] [Related]
55. High-dose chemotherapy with hematopoietic rescue in breast cancer: from theory to practice.
Bezwoda WR
Cancer Chemother Pharmacol; 1997; 40 Suppl():S79-87. PubMed ID: 9272140
[TBL] [Abstract][Full Text] [Related]
56. Platelets acquire a secretion defect after high-dose chemotherapy.
Panella TJ; Peters W; White JG; Hannun YA; Greenberg CS
Cancer; 1990 Apr; 65(8):1711-6. PubMed ID: 2317753
[TBL] [Abstract][Full Text] [Related]
57. Interferon-gamma for delayed pulmonary toxicity syndrome resistant to steroids.
Suratt BT; Lynch DA; Cool CD; Jones RB; Brown KK
Bone Marrow Transplant; 2003 May; 31(10):939-41. PubMed ID: 12748674
[TBL] [Abstract][Full Text] [Related]
58. Oxidative stress and inflammation contribute to lung toxicity after a common breast cancer chemotherapy regimen.
Abushamaa AM; Sporn TA; Folz RJ
Am J Physiol Lung Cell Mol Physiol; 2002 Aug; 283(2):L336-45. PubMed ID: 12114195
[TBL] [Abstract][Full Text] [Related]
59. Autologous bone marrow transplantation and factor XII, factor VII, and protein C deficiencies. Report of a new association and its possible relationship to endothelial cell injury.
Kaufman PA; Jones RB; Greenberg CS; Peters WP
Cancer; 1990 Aug; 66(3):515-21. PubMed ID: 2114212
[TBL] [Abstract][Full Text] [Related]
60. The controversy over high-dose chemotherapy with autologous bone marrow transplant for breast cancer.
Mello MM; Brennan TA
Health Aff (Millwood); 2001; 20(5):101-17. PubMed ID: 11558695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
